94 related articles for article (PubMed ID: 9920111)
1. Development of a luminescent bioassay for thyroid stimulating antibodies.
Evans C; Morgenthaler NG; Lee S; Llewellyn DH; Clifton-Bligh R; John R; Lazarus JH; Chatterjee VK; Ludgate M
J Clin Endocrinol Metab; 1999 Jan; 84(1):374-7. PubMed ID: 9920111
[TBL] [Abstract][Full Text] [Related]
2. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
[TBL] [Abstract][Full Text] [Related]
3. A luminescent bioassay for thyroid blocking antibodies.
Jordan NJ; Rinderle C; Ashfield J; Morgenthaler NG; Lazarus J; Ludgate M; Evans C
Clin Endocrinol (Oxf); 2001 Mar; 54(3):355-64. PubMed ID: 11298088
[TBL] [Abstract][Full Text] [Related]
4. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study.
Diana T; Brown RS; Bossowski A; Segni M; Niedziela M; König J; Bossowska A; Ziora K; Hale A; Smith J; Pitz S; Kanitz M; Kahaly GJ
J Clin Endocrinol Metab; 2014 May; 99(5):1648-55. PubMed ID: 24517152
[TBL] [Abstract][Full Text] [Related]
6. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
7. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
8. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
9. A rapid homogenous bioassay for detection of thyroid-stimulating antibodies based on a luminescent cyclic AMP biosensor.
Miao LY; Kim HJ; Whitlatch K; Jaiswal D; Navarro A; Egan R; Olivo PD
J Immunol Methods; 2022 Feb; 501():113199. PubMed ID: 34871593
[TBL] [Abstract][Full Text] [Related]
10. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a Bridge Immunoassay with Two Bioassays for Thyrotropin Receptor Antibody Detection and Differentiation.
Allelein S; Diana T; Ehlers M; Kanitz M; Hermsen D; Schott M; Kahaly GJ
Horm Metab Res; 2019 Jun; 51(6):341-346. PubMed ID: 31207654
[TBL] [Abstract][Full Text] [Related]
12. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.
Vitti P; Elisei R; Tonacchera M; Chiovato L; Mancusi F; Rago T; Mammoli C; Ludgate M; Vassart G; Pinchera A
J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393
[TBL] [Abstract][Full Text] [Related]
13. Measurement of thyroid stimulating immunoglobulins in a new cell line transfected with a functional human TSH receptor (JPO9 cells), compared with an assay using FRTL-5 cells.
Michelangeli VP; Munro DS; Poon CW; Frauman AG; Colman PG
Clin Endocrinol (Oxf); 1994 May; 40(5):645-52. PubMed ID: 7912172
[TBL] [Abstract][Full Text] [Related]
14. A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease.
Watson PF; Ajjan RA; Phipps J; Metcalfe R; Weetman AP
Clin Endocrinol (Oxf); 1998 Nov; 49(5):577-81. PubMed ID: 10197071
[TBL] [Abstract][Full Text] [Related]
15. Standardization of a bioassay for thyrotropin receptor stimulating autoantibodies.
Diana T; Kanitz M; Lehmann M; Li Y; Olivo PD; Kahaly GJ
Thyroid; 2015 Feb; 25(2):169-75. PubMed ID: 25317659
[TBL] [Abstract][Full Text] [Related]
16. [Detection of thyroid stimulating antibodies and TSH binding inhibitor immunoglobulins in patients with thyroid diseases and its clinical applications].
Liu C; Yin F; Zhang Z
Zhonghua Nei Ke Za Zhi; 1995 Feb; 34(2):105-7. PubMed ID: 7796654
[TBL] [Abstract][Full Text] [Related]
17. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
18. Detection of thyroid stimulating (TSAB)- and thyrotropin stimulation blocking (TSBAB) antibodies with CHO cell lines expressing different TSH-receptor numbers.
Wallaschofski H; Paschke R
Clin Endocrinol (Oxf); 1999 Mar; 50(3):365-72. PubMed ID: 10435063
[TBL] [Abstract][Full Text] [Related]
19. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of a chimeric TSH receptor (Mc4)-based bioassay for Graves' disease.
Lee JI; Jang HW; Kim SK; Choi JY; Kim JY; Hur KY; Kim JH; Min YK; Chung JH; Kim SW
Korean J Intern Med; 2011 Jun; 26(2):179-86. PubMed ID: 21716594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
